Tohoku ChemicalTOHOKU CHEMICAL CO., LTD.7446東証スタンダード卸売業FY ending Sep 2025, consolidated, J-GAAP

Tohoku Chemical FY ending Sep 2024 results

About 50% of Tohoku Chemical's sales come from Industry sales group, with Medical sales group and Academia, Life science sales group making up much of the rest.

Out of every ¥100 of sales, about ¥1 is left as operating profit.

Revenue changed -8.4% from the prior year, operating profit -53.0%.

Revenue and profit pattern

Revenue and profit down

Revenue -8.4% · profit -53.0%, calculated from disclosed figures.

Operating leverage: 6.32× (profit growth ÷ revenue growth)

What changed from last year

FY ending Sep 2023 → FY ending Sep 2024

Revenue
-8.4%¥35.1B → ¥32.2B
Gross profit
-6.1%¥3.34B → ¥3.14B
Operating income
-53.0%¥751M → ¥353.3M
Net income attributable to owners
-57.3%¥556.2M → ¥237.5M
Operating cash flow
-182.3%¥1.27B → -¥1.04B
Free cash flow
-232.4%¥919.1M → -¥1.22B

Where the money goes

FY ending Sep 2023 → FY ending Sep 2024

Where ¥100 of sales goes

For every ¥100 Tohoku Chemical sells, how much goes where, and how much is kept.

FY ending Sep 2024
Cost of sales
¥90
SG&A
¥9
Operating profit
¥1
Net profit kept
¥1

Annual margin trends

Gross margin9.8%
FY ending Sep 2019: 8.9%8.9%FY ending Sep 2020: 9.0%9.0%FY ending Sep 2021: 8.8%8.8%FY ending Sep 2022: 9.3%9.3%FY ending Sep 2023: 9.5%9.5%FY ending Sep 2024: 9.8%9.8%FY19FY20FY21FY22FY23FY24
Operating margin1.1%
FY ending Sep 2019: 0.9%0.9%FY ending Sep 2020: 1.2%1.2%FY ending Sep 2021: 2.0%2.0%FY ending Sep 2022: 2.5%2.5%FY ending Sep 2023: 2.1%2.1%FY ending Sep 2024: 1.1%1.1%FY19FY20FY21FY22FY23FY24
Net margin0.7%
FY ending Sep 2019: 0.7%0.7%FY ending Sep 2020: 1.2%1.2%FY ending Sep 2021: 1.4%1.4%FY ending Sep 2022: 1.8%1.8%FY ending Sep 2023: 1.6%1.6%FY ending Sep 2024: 0.7%0.7%FY19FY20FY21FY22FY23FY24

Aligned fiscal years compare the shares of revenue remaining as gross, core, and net profit. Missing years are left unconnected.

Which businesses earn the money

Revenue by business segment, and the profit each one keeps.

FY ending Sep 2024

Profit by segment

※ Segments without disclosed profit are drawn entirely as costs

※ Segment figures include inter-segment sales and do not sum to the company total

Sources

Show source documents (6)
  • EDINET (FSA Japan)

    有価証券報告書-第74期(2024/10/01-2025/09/30)

    ID S100XAMG2025-12-17Open
  • EDINET (FSA Japan)

    有価証券報告書-第73期(2023/10/01-2024/09/30)

    ID S100UZ2P2024-12-20Open
  • EDINET (FSA Japan)

    有価証券報告書-第72期(2022/10/01-2023/09/30)

    ID S100SHTA2023-12-21Open
  • EDINET (FSA Japan)

    訂正有価証券報告書-第71期(2021/10/01-2022/09/30)

    ID S100RSYI2023-09-05Open
  • EDINET (FSA Japan)

    有価証券報告書

    ID S100N3CZ2021-12-21Open
  • EDINET (FSA Japan)

    有価証券報告書-第69期(令和1年10月1日-令和2年9月30日)

    ID S100KE0G2020-12-18Open

Extracted from XBRL: 52 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Other periods

Analyze this page with AI

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.